These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26863036)

  • 21. [How safe are ADHD drugs?].
    Schwarz R; Muskalla B
    Kinderkrankenschwester; 2005 Oct; 24(10):437. PubMed ID: 16262203
    [No Abstract]   [Full Text] [Related]  

  • 22. Focalin XR for ADHD.
    Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
    [No Abstract]   [Full Text] [Related]  

  • 23. Drugs and children.
    Pinkham JR
    ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
    [No Abstract]   [Full Text] [Related]  

  • 24. [Infantile psychosis secondary to methylphenidate].
    Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
    Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
    [No Abstract]   [Full Text] [Related]  

  • 25. Methylphenidate as a possible cause of thrombocytopenia.
    Kuperman AA; Yaniv I; Stahl B; Tamary H
    Ann Pharmacother; 2003; 37(7-8):1146. PubMed ID: 12841835
    [No Abstract]   [Full Text] [Related]  

  • 26. Methylphenidate associated vitiligo in a child: A case report.
    Guler Aksu G; Akdere P; Toros F
    Asia Pac Psychiatry; 2019 Sep; 11(3):e12351. PubMed ID: 30821429
    [No Abstract]   [Full Text] [Related]  

  • 27. Bruxism arising during monotherapy with methylphenidate.
    Mendhekar DN; Andrade C
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):537-8. PubMed ID: 18928420
    [No Abstract]   [Full Text] [Related]  

  • 28. Trichotillomania in Attention-Deficit/Hyperactivity Disorder Under Methylphenidate Treatment.
    Kara T; Akaltun İ
    J Clin Psychopharmacol; 2017 Aug; 37(4):484. PubMed ID: 28492426
    [No Abstract]   [Full Text] [Related]  

  • 29. Status epilepticus associated with the administration of long-acting methylphenidate in a 7-year-old girl.
    Goetz M; Surman CB; Mlynarova E; Krsek P
    J Clin Psychopharmacol; 2012 Apr; 32(2):300-2. PubMed ID: 22388167
    [No Abstract]   [Full Text] [Related]  

  • 30. Explosive outbursts associated with methylphenidate.
    Adrian N
    J Am Acad Child Adolesc Psychiatry; 2001 Jun; 40(6):618-9. PubMed ID: 11392335
    [No Abstract]   [Full Text] [Related]  

  • 31. Methylphenidate and somatic hallucinations.
    Rashid J; Mitelman S
    J Am Acad Child Adolesc Psychiatry; 2007 Aug; 46(8):945-946. PubMed ID: 17667474
    [No Abstract]   [Full Text] [Related]  

  • 32. OROS methylphenidate-induced skin eruptions.
    Coskun M; Tutkunkardas MD; Zoroglu S
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):593-4. PubMed ID: 19877987
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malnutrition in children with DAMP?].
    Andersen LL
    Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
    [No Abstract]   [Full Text] [Related]  

  • 34. Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
    McGough JJ; McBurnett K; Bukstein O; Wilens TE; Greenhill L; Lerner M; Stein M
    J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):351-6. PubMed ID: 16768642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention deficit hyperactivity disorder: part III.
    Ryan-Krause P
    J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
    Hollis CP; Thompson A
    Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal methylphenidate (Daytrana) for ADHD.
    Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
    [No Abstract]   [Full Text] [Related]  

  • 38. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
    Lurie S; O'Quinn A
    J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylphenidate induction of complex visual hallucinations.
    Halevy A; Shuper A
    J Child Neurol; 2009 Aug; 24(8):1005-7. PubMed ID: 19502578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methylphenidate in attention deficit hyperactivity disorder and bipolar disorder.
    Kummer A; Teixeira A
    Australas Psychiatry; 2008 Dec; 16(6):458-9. PubMed ID: 19034996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.